Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

Item

http://www.wikidata.org/entity/Q35674320

Q35674320

about

Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update Lipid-lowering agents in the management of nonalcoholic fatty liver disease Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings.Blood pressure j-curve: current concepts Metformin and its clinical use: new insights for an old drug in clinical practice.Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults.Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study Blood pressure levels and stroke: J-curve phenomenon?Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients.Non-alcoholic fatty liver disease: a diabetologist's perspective.Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease.Statins and nonalcoholic fatty liver disease: a bright future?Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality

P2860

Q26997059-6A150817-F525-4D39-97AA-FA491277C0B9 Q27024352-6EAA1ED3-25F9-4F5F-989F-F8476E15C13F Q30622511-23D8D88C-290C-4728-A4C6-A80227D65371 Q33935273-7CE50050-0D1D-4D68-B413-48DBFCBEE9FB Q34334313-9164EA95-CCFB-419C-9E86-8421010C9DA8 Q35232279-145D9FC9-1F24-42B8-B2D5-615A670A40EF Q35622817-E67F68BF-5C7B-44A0-AA2D-6FC2E5E8FDC1 Q35681989-EA4A0C46-B671-45A0-B044-0C339489FA98 Q35819589-534995A3-B95E-4C7D-9359-E47778F336A3 Q35843906-DA794FB6-82DC-4335-9752-7054748C61A8 Q36374410-6FEEB687-EBED-49D3-9F0B-75F7F2F9770A Q36423076-DBAE4356-2E54-44F1-BA9A-4E964D85EE91 Q36829065-55078F27-9CEC-4353-B050-20928534DAC1 Q36984049-F5264998-DED1-4887-B9FF-05F9D65FA7F0 Q37337561-1BAEC6F2-9E99-454A-B12B-290CD3FC2851 Q37669343-65CB353B-747F-4DE1-BEB6-6674E480EFD4 Q38167264-E74D2DD1-BA98-4327-8DD2-380A44220E31 Q38867031-C7232DEF-9ACB-4D18-97C9-C600A875AAF8 Q45112909-223F59FF-76A0-4A9F-830D-935E12F81890 Q49190671-FA0D96CE-3618-4AC3-8FD3-65FDCA608AFD Q51387608-76989B80-0707-4F75-AA93-F707ED698E50 Q57070326-9DCFD558-E06C-4080-AD4C-745043BAA493

P2860

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

Item

http://www.wikidata.org/entity/Q35674320

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@ast

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@en

type

Item

label

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@ast

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@en

prefLabel

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@ast

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@en

P1476

Safety and impact on cardiovas ...... f the randomised ATTEMPT study

@en

P2093

Asterios Karagiannis

http://www.w3.org/2001/XMLSchema#string

Dimitri P Mikhailidis

http://www.w3.org/2001/XMLSchema#string

Eleni Theocharidou

http://www.w3.org/2001/XMLSchema#string

Konstantinos Tziomalos

http://www.w3.org/2001/XMLSchema#string

Olga Giouleme

http://www.w3.org/2001/XMLSchema#string

Themistoklis Vassiliadis

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Therapy of NAFLD: insulin sensitizing agents.

Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.

Orlistat-associated adverse effects and drug interactions: a critical review.

Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

Review article: Drug therapy for non-alcoholic fatty liver disease.

P304

796-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2011.25554

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Evangelos N Liberopoulos

Vasilios G. Athyros

Emmanuel Ganotakis

Moses Elisaf

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221793114

http://www.w3.org/2001/XMLSchema#string

P698

22291824

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3258797

http://www.w3.org/2001/XMLSchema#string

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

about

P2860

P2860

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932